FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147048440> ?p ?o ?g. }

• W2147048440 endingPage "563" @default.
• W2147048440 startingPage "556" @default.
• W2147048440 abstract "Background: Lowering cholesterol is associated with reduced CNS amyloid deposition and increased dietary cholesterol increases amyloid accumulation in animal studies. Epidemiologic data suggest that use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG - CoA) reductase inhibitors (statins) may decrease the risk of Alzheimer disease (AD) and a single-site trial suggested possible benefit in cognition with statin treatment in AD, supporting the hypothesis that statin therapy is useful in the treatment of AD. Objective: To determine if the lipid-lowering agent simvastatin slows the progression of symptoms in AD. Methods: This randomized, double-blind, placebo-controlled trial of simvastatin was conducted in individuals with mild to moderate AD and normal lipid levels. Participants were randomly assigned to receive simvastatin, 20 mg/day, for 6 weeks then 40 mg per day for the remainder of 18 months or identical placebo. The primary outcome was the rate of change in the Alzheimer's Disease Assessment Scale–cognitive portion (ADAS-Cog). Secondary outcomes measured clinical global change, cognition, function, and behavior. Results: A total of 406 individuals were randomized: 204 to simvastatin and 202 to placebo. Simvastatin lowered lipid levels but had no effect on change in ADAS-Cog score or the secondary outcome measures. There was no evidence of increased adverse events with simvastatin treatment. Conclusion: Simvastatin had no benefit on the progression of symptoms in individuals with mild to moderate AD despite significant lowering of cholesterol. Classification of evidence: This study provides Class I evidence that simvastatin 40 mg/day does not slow decline on the ADAS-Cog. Aβ= : amyloid β peptide; AChE= : acetylcholinesterase; AD= : Alzheimer disease; ADAS-Cog= : Alzheimer's Disease Assessment Scale–cognitive portion; ADCS= : Alzheimer's Disease Cooperative Study; ADCS-ADL= : Alzheimer's Disease Cooperative Study Activities of Daily Living; ADCS-CGIC= : Alzheimer's Disease Cooperative Study Clinical Global Impression of Change; ADCS-RUI= : Alzheimer's Disease Cooperative Study Resource Use Instrument; ALT= : alanine aminotransferase; AST= : aspartate aminotransferase; ATP= : Adult Treatment Panel; CRP= : C-reactive protein; GEE= : generalized estimating equation; HDL= : high-density lipoprotein; HMG-CoA= : 3-hydroxy-3-methylglutaryl coenzyme A; ITT= : intent-to-treat; LDL= : low-density lipoprotein; MMSE= : Mini-Mental State Examination; NPI= : Neuropsychiatric Inventory; QOL= : quality of life" @default.
• W2147048440 created "2016-06-24" @default.
• W2147048440 creator A5010928244 @default.
• W2147048440 creator A5013224142 @default.
• W2147048440 creator A5026572152 @default.
• W2147048440 creator A5034225628 @default.
• W2147048440 creator A5040374029 @default.
• W2147048440 creator A5074237316 @default.
• W2147048440 creator A5084326649 @default.
• W2147048440 date "2011-07-27" @default.
• W2147048440 modified "2023-10-18" @default.
• W2147048440 title "A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease" @default.
• W2147048440 cites W102617557 @default.
• W2147048440 cites W1164896577 @default.
• W2147048440 cites W1447623510 @default.
• W2147048440 cites W1847168837 @default.
• W2147048440 cites W1953027527 @default.
• W2147048440 cites W1965050626 @default.
• W2147048440 cites W1972294144 @default.
• W2147048440 cites W1982816514 @default.
• W2147048440 cites W1984964878 @default.
• W2147048440 cites W2003188394 @default.
• W2147048440 cites W2006166262 @default.
• W2147048440 cites W2014942056 @default.
• W2147048440 cites W2024719735 @default.
• W2147048440 cites W2025916746 @default.
• W2147048440 cites W2030025114 @default.
• W2147048440 cites W2036362108 @default.
• W2147048440 cites W2036697335 @default.
• W2147048440 cites W2037477464 @default.
• W2147048440 cites W2039934896 @default.
• W2147048440 cites W2052862001 @default.
• W2147048440 cites W2064032283 @default.
• W2147048440 cites W2089044080 @default.
• W2147048440 cites W2097992844 @default.
• W2147048440 cites W2098878950 @default.
• W2147048440 cites W2100358124 @default.
• W2147048440 cites W2105071925 @default.
• W2147048440 cites W2108326377 @default.
• W2147048440 cites W2112562667 @default.
• W2147048440 cites W2133025814 @default.
• W2147048440 cites W2135631433 @default.
• W2147048440 cites W2138883123 @default.
• W2147048440 cites W2145053304 @default.
• W2147048440 cites W2147782235 @default.
• W2147048440 cites W2155508918 @default.
• W2147048440 cites W2156220037 @default.
• W2147048440 cites W2157519191 @default.
• W2147048440 cites W2165136235 @default.
• W2147048440 cites W2231692891 @default.
• W2147048440 cites W2943352209 @default.
• W2147048440 cites W752895202 @default.
• W2147048440 doi "https://doi.org/10.1212/wnl.0b013e318228bf11" @default.
• W2147048440 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3149154" @default.
• W2147048440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21795660" @default.
• W2147048440 hasPublicationYear "2011" @default.
• W2147048440 type Work @default.
• W2147048440 sameAs 2147048440 @default.
• W2147048440 citedByCount "262" @default.
• W2147048440 countsByYear W21470484402012 @default.
• W2147048440 countsByYear W21470484402013 @default.
• W2147048440 countsByYear W21470484402014 @default.
• W2147048440 countsByYear W21470484402015 @default.
• W2147048440 countsByYear W21470484402016 @default.
• W2147048440 countsByYear W21470484402017 @default.
• W2147048440 countsByYear W21470484402018 @default.
• W2147048440 countsByYear W21470484402019 @default.
• W2147048440 countsByYear W21470484402020 @default.
• W2147048440 countsByYear W21470484402021 @default.
• W2147048440 countsByYear W21470484402022 @default.
• W2147048440 countsByYear W21470484402023 @default.
• W2147048440 crossrefType "journal-article" @default.
• W2147048440 hasAuthorship W2147048440A5010928244 @default.
• W2147048440 hasAuthorship W2147048440A5013224142 @default.
• W2147048440 hasAuthorship W2147048440A5026572152 @default.
• W2147048440 hasAuthorship W2147048440A5034225628 @default.
• W2147048440 hasAuthorship W2147048440A5040374029 @default.
• W2147048440 hasAuthorship W2147048440A5074237316 @default.
• W2147048440 hasAuthorship W2147048440A5084326649 @default.
• W2147048440 hasBestOaLocation W21470484402 @default.
• W2147048440 hasConcept C104950815 @default.
• W2147048440 hasConcept C126322002 @default.
• W2147048440 hasConcept C134018914 @default.
• W2147048440 hasConcept C134651460 @default.
• W2147048440 hasConcept C142724271 @default.
• W2147048440 hasConcept C168563851 @default.
• W2147048440 hasConcept C181199279 @default.
• W2147048440 hasConcept C197934379 @default.
• W2147048440 hasConcept C204787440 @default.
• W2147048440 hasConcept C27081682 @default.
• W2147048440 hasConcept C2776329913 @default.
• W2147048440 hasConcept C2776839432 @default.
• W2147048440 hasConcept C2778163477 @default.
• W2147048440 hasConcept C2779134260 @default.
• W2147048440 hasConcept C2779483572 @default.
• W2147048440 hasConcept C2984863031 @default.
• W2147048440 hasConcept C502032728 @default.
• W2147048440 hasConcept C55493867 @default.

• next